Supplement monograph
Red Yeast Rice
A cholesterol-positioned supplement where monacolin K exposure, statin overlap, liver context, and citrinin quality testing matter more than natural-product marketing.
Practical read
Treat red yeast rice like a medication-context review item before any timing decision. If lipid medication, liver history, pregnancy, or unexplained muscle symptoms are involved, route the plan through clinician guidance.
Decision frame
Red Yeast Rice: what to check before it earns a slot
Timing rule
Treat red yeast rice like a medication-context review item before any timing decision. If lipid medication, liver history, pregnancy, or unexplained muscle symptoms are involved, route the plan through clinician guidance.
Form lens
Safety lens
Best fit
- Lipid-stack safety audits
- Statin-overlap screening
- Product-quality claim review
Form notes
- Standardized red yeast rice capsules: exposure can still vary
- Cholesterol blends: highest hidden-overlap risk
- Products claiming no monacolin K: may not match the intended effect
Watchouts
- Can contain monacolin K, chemically identical to lovastatin
- Statin overlap and liver or muscle symptoms need clinician review
- Quality concerns include variable monacolin content and citrinin contamination
Sources and next checks
Evidence Brief
Get supplement timing and safety notes as they ship.
Monthly evidence briefs. No hype, no disease claims, no influencer supplement stacks.
These statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease. Generated by AI. Always verify with a healthcare professional. Educational information only. Not a substitute for professional medical advice.